Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
Hormones & Cancer
|
December 14, 2011
Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
E Baudin, S Leboulleux, A Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 27, 1999
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors
E Baudin, J M Bidart, P Rougier, et al.
Neuroendocrinology
|
January 6, 2016
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R Garcia-Carbonero, H Sorbye, E Baudin, et al.
Nature Nanotechnology
|
March 18, 2025
Time-resolved sensing of electromagnetic fields with single-electron interferometry
H Bartolomei, E Frigerio, M Ruelle, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Th Delaunoit, M Ducreux, V Boige, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2016
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer
Livia Lamartina, S Ippolito, M Danis, et al.
Oncology
|
April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
M P Ducreux, V Boige, S Leboulleux, et al.
Science (New York, N.Y.)
|
July 3, 2025
Time-domain braiding of anyons
M Ruelle, E Frigerio, E Baudin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
T Walter, D Planchard, K Bouledrak, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
Hormones & Cancer
|
December 14, 2011
Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
E Baudin, S Leboulleux, A Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 27, 1999
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors
E Baudin, J M Bidart, P Rougier, et al.
Neuroendocrinology
|
January 6, 2016
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
R Garcia-Carbonero, H Sorbye, E Baudin, et al.
Nature Nanotechnology
|
March 18, 2025
Time-resolved sensing of electromagnetic fields with single-electron interferometry
H Bartolomei, E Frigerio, M Ruelle, et al.
Endocrine-Related Cancer
|
December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Th Delaunoit, M Ducreux, V Boige, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2016
Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer
Livia Lamartina, S Ippolito, M Danis, et al.
Oncology
|
April 29, 2006
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas
M P Ducreux, V Boige, S Leboulleux, et al.
Science (New York, N.Y.)
|
July 3, 2025
Time-domain braiding of anyons
M Ruelle, E Frigerio, E Baudin, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
T Walter, D Planchard, K Bouledrak, et al.
Page
of 13